Publication
Article
BioPharm International
Single-Use Bioreactors Unwrap Commercial Manufacturing Options
Author(s):
This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.
Several companies have invested in 2000-L single-use bioreactors to expand production capabilities, including Thermo Fisher Scientific, GE Healthcare, Pall Biotech, and Sartorius Stedim Biotech. This article highlights the features, functions, and capacities of several large-volume bioreactors by these companies that are used in the market today.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
Article Details
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 24–27
Citation
When referring to this article, please cite it as A. Lowry, "Single-Use Bioreactors Unwrap Commercial Manufacturing Options," BioPharm International Single-Use Systems eBook (June 2019).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
